Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

BACKGROUND: Antiviral treatment of patients with chronic hepatitis B (CHB) in the grey zone of treatment comands risk management in order to optimize the health outcome. In this sense, the identification of HBV mutants related with an increased risk of hepatocellular carcinoma (HCC) could be useful...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil-García, Ana Isabel, Madejón, Antonio, Francisco-Recuero, Irene, López-López, Ana, Villafranca, Emiliana, Romero, Miriam, García, Araceli, Olveira, Antonio, Mena, Rocío, Larrubia, Juan Ramón, García-Samaniego, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801187/
https://www.ncbi.nlm.nih.gov/pubmed/31636479
http://dx.doi.org/10.3748/wjg.v25.i38.5883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801187/
https://www.ncbi.nlm.nih.gov/pubmed/31636479
http://dx.doi.org/10.3748/wjg.v25.i38.5883

Ejemplares similares